| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |